Cidara Therapeutics
CDTX
CDTX
54 hedge funds and large institutions have $83.6M invested in Cidara Therapeutics in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $89.3M → $83.6M (-$5.72M)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
54
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.8M | |
| 2 | +$1.9M | |
| 3 | +$1.13M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.06M |
| 5 |
Renaissance Technologies
New York
|
+$750K |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$3.99M | |
| 3 | -$970K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$955K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$712K |